Results for tag: "16 Dehydropregnenolone Acetate"

Dehydropregnenolone Acetate (DPA) is a pharmaceutical intermediate used in the production of various steroid hormones. It is a key intermediate in the synthesis of progesterone, corticosteroids, and androgens. DPA is also used in the production of contraceptives, anti-inflammatory drugs, and other therapeutic agents. DPA is produced through a multi-step process involving the reaction of pregnenolone with acetic anhydride. The resulting product is then purified and crystallized to obtain the desired purity. The DPA market is highly competitive, with a number of manufacturers offering a wide range of products. The market is driven by the increasing demand for steroid hormones and other therapeutic agents. The availability of raw materials and the increasing demand for DPA in the pharmaceutical industry are expected to drive the growth of the market. Some of the major companies in the DPA market include Merck KGaA, Pfizer, Sanofi, Novartis, and GlaxoSmithKline. Show Less Read more